Griffith University’s Institute for Glycomics farewells Director Professor Mark von Itzstein AO
Griffith University is bidding a grateful farewell to community champion and Director of the Institute for Glycomics, Professor Mark von...
Griffith University is bidding a grateful farewell to community champion and Director of the Institute for Glycomics, Professor Mark von...
Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.
Griffith University has launched two cancer research centres backed by $4.6 million in funding from the Australian Cancer Research Foundation this month.
Institute for Glycomics researchers receive funding boost in their fight against cancer with $2.6 million awarded by the Australian Cancer Research Foundation.
Griffith University’s Institute for Glycomics has been awarded $2.66 million in Ideas Grant funding from the National Health and Medical...
Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.
Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
Researchers develop drug target to tackle multi-drug resistant lung bacterium.
We’re excited to announce the launch of the Bourne Foundation Nuclear Magnetic Resonance (NMR) Facility, an institute core facility that...
The first week of October brought with it a flurry of activity at Griffith University’s Institute for Glycomics as they...